The Cooper Companies, Inc. (NASDAQ:COO) Stock Position Lifted by Davis R M Inc.

Davis R M Inc. grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 273.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,041 shares of the medical device company’s stock after buying an additional 4,423 shares during the period. Davis R M Inc.’s holdings in Cooper Companies were worth $613,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Cooper Companies by 303.0% in the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after purchasing an additional 17,367,502 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Cooper Companies by 273.8% in the 1st quarter. Bank of New York Mellon Corp now owns 1,731,194 shares of the medical device company’s stock worth $175,647,000 after purchasing an additional 1,268,109 shares during the last quarter. Congress Asset Management Co. MA lifted its holdings in shares of Cooper Companies by 252.4% in the 1st quarter. Congress Asset Management Co. MA now owns 1,263,754 shares of the medical device company’s stock worth $128,220,000 after purchasing an additional 905,173 shares during the last quarter. Intermede Investment Partners Ltd lifted its holdings in shares of Cooper Companies by 220.6% in the 1st quarter. Intermede Investment Partners Ltd now owns 1,190,001 shares of the medical device company’s stock worth $120,738,000 after purchasing an additional 818,837 shares during the last quarter. Finally, Westfield Capital Management Co. LP lifted its holdings in shares of Cooper Companies by 338.3% in the 1st quarter. Westfield Capital Management Co. LP now owns 776,971 shares of the medical device company’s stock worth $78,831,000 after purchasing an additional 599,697 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ COO traded down $0.52 during mid-day trading on Tuesday, reaching $90.95. The company had a trading volume of 1,345,119 shares, compared to its average volume of 1,128,327. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34. The stock has a market cap of $18.11 billion, a PE ratio of 53.68, a P/E/G ratio of 2.25 and a beta of 0.98. The company has a 50-day moving average price of $91.72 and a two-hundred day moving average price of $94.32. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $104.07.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.02. The business had revenue of $942.60 million for the quarter, compared to analysts’ expectations of $948.07 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The company’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.77 EPS. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.57 earnings per share for the current year.

Analyst Ratings Changes

COO has been the topic of several recent research reports. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and lifted their target price for the company from $107.00 to $115.00 in a research note on Tuesday, July 16th. Robert W. Baird lifted their target price on Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research note on Friday, May 31st. Piper Sandler reaffirmed an “overweight” rating and set a $115.00 target price on shares of Cooper Companies in a research note on Wednesday, July 3rd. Finally, Citigroup lifted their target price on Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $111.78.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.